Cell Marque Cancer Webinar Series

Skin Cancer and Immunohistochemistry – June 22, 2016

Speaker: Jeff Gordon

Abstract
Skin cancer is by far the most prevalent cancer. Each year, approximately 3.4 million people in the US alone are diagnosed with some form of skin cancer. Skin cancer can be highly treatable if it is detected and classified early, and this detection and classification is often aided by immunohistochemistry. This presentation covers many of the basic science, facts, and statistics of skin cancer, as well as the utility of immunohistochemical testing with markers such as S-100, SOX-10, Ber-Ep4, and HHV-8 in the accurate diagnosis and survival rates of skin cancer. Continuing education credits for attending this webinar will be offered through the National Society of Histotechnology.

Topics will include:

  • The advancements in immunohistochemical methods that enhance skin tissue pathology
  • The pathology of skin cancer
  • Innovative detection markers including SOX-10, MiTF, PNL2, and KBA.62
  • Demonstration of advanced staining on clinical samples.

Colorectal Cancer and Immunohistochemistry – March 30, 2016

Speaker: Jeff Gordon

Abstract
Colorectal cancer is the third most commonly diagnosed cancer in men and women, and is the second leading overall cause of cancer deaths in the United States. Each year, the CDC reports that approximately 135,000 people are diagnosed with colorectal cancer, and over 50,000 succumb each year to the illness. The National Cancer Institute cites a decline in the mortality rate of colorectal cancer due to advanced screening and early diagnosis. Immunohistochemistry has served as the catalyst for these advancements in colorectal cancer diagnosis. This presentation covers many of the basic science, facts, and statistics of colorectal cancer, as well as the utility of immunohistochemical testing with markers such as cadherin­17, CDX­2, SATB2, and the mismatch repair proteins in the accurate diagnosis and survival rates of colorectal cancer.

Topics will include:

  • Basic pathology of colorectal cancer
  • Innovative detection biomarkers including cadherin­17, CDX­2, and SATB2
  • Demonstration of advanced staining on clinical samples
  • Continuing education credit is available for attendance of this webinar through NSH

Breast Cancer and Immunohistochemistry – October 27, 2015

Speaker: Jeff Gordon

Abstract
Breast cancer is the most commonly diagnosed cancer in women, and is the second leading cause of death in women. Each year, over 220,000 women (as well as over 2000 men) are diagnosed with breast cancer, and over 40,000 succumb each year to the illness. With constant advancement of treatment options, the importance of accurate diagnosis and detection of breast cancer becomes more and more relevant to the survival of the patient. Immunohistochemistry has served as the catalyst for these advancements in breast cancer diagnosis. This presentation covers many of the basic science, facts, and statistics of breast cancer, as well as the utility of immunohistochemical testing with markers such as e-cadherin, p120 catenin, mammaglobin, and GATA3 in the accurate diagnosis and survival rates of breast cancer.

Topics will include:

  • Basic pathology of breast cancer
  • Innovative detection biomarkers including e-cadeherin p120 catenin, mammaglobin, and GATA3
  • Demonstration of advanced staining on clinical samples
  • Continuing education credit is available for attendance of this webinar through NSH